Finance

Lists
N1A:FRA
Navamedic ASA
€1.24
-1.20%
(-0.015) 1D
Sep 8, 10:00:00 PM GMT+2  ·   EUR
All symbols
SymbolPriceChange% Change
Generating top insights for N1A...
Open
€1.25
High
€1.25
Low
€1.24
Avg. vol.
0.00
Volume
0.00
52-wk high
€2.18
52-wk low
€1.24
No. of employees
38
Open
€1.25
High
€1.25
Low
€1.24
Avg. vol.
0.00
Volume
0.00
52-wk high
€2.18
52-wk low
€1.24
No. of employees
38
About Navamedic ASA
CEOKathrine Gamborg Andreassen
Employees38
Founded2002
Headquarters-
SectorPharmaceutical industry
Previous reportsAll values in NOK
Loading Previous Earnings...
Income statement
Revenue
Net income
All values in NOK
Sep 2025
Dec 2025
Mar 2026
Jun 2026
Revenue
138.92M
157.14M
137.90M
140.35M
Cost of goods sold
86.81M
96.64M
83.47M
81.22M
Cost of revenue
86.81M
96.64M
83.47M
81.22M
Research and development expenses
-
-
-
-
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
40.81M
-6.73M
18.24M
22.88M
Operating expense
50.04M
61.75M
52.62M
57.58M
Total operating expenses
136.85M
158.39M
136.08M
138.80M
Operating income
2.07M
-1.25M
1.82M
1.55M
Other non operating income
-
-1.99M
1.00K
1.00K
EBT including unusual items
-3.78M
-8.27M
2.65M
-12.22M
EBT excluding unusual items
-1.52M
6.05M
-1.80M
-5.61M
Income tax expense
-282.00K
2.78M
2.76M
-3.72M
Effective tax rate
7.47%
-33.64%
104.42%
30.46%
Other operating expenses
-
53.86M
23.69M
23.18M
Net income
-3.49M
-11.06M
-117.00K
-8.50M
Net profit margin
-2.51%
-7.04%
-0.08%
-6.05%
Earnings per share
-
-
-0.00
-0.12
Interest and investment income
-
9.18M
-
-
Interest expense
-3.59M
-
-5.49M
-4.15M
Net interest expenses
-3.59M
9.18M
-5.49M
-4.15M
Depreciation and amortization charges
941.00K
1.06M
10.68M
1.79M
EBITDA
12.18M
9.06M
12.50M
13.06M
Gain or loss from assets sale
-
-
-
-
AI content may include mistakes. Learn more
Google apps